Evaluation of IFN-gamma response to rotavirus and non-structural protein NSP4 of rotavirus in children following severe rotavirus diarrhea.
BACKGROUND
Rotavirus (RV) is the commonest cause of severe gastroenteritis in young children worldwide. However the natural immune mechanisms controlling and preventing rotavirus disease in humans are not fully understood.


OBJECTIVE
To examine cellular immune responses to whole rotavirus (vaccine strain, 116E) and non-structural protein-4 (116E-NSP4) in children during natural rotavirus-infection.


METHODS
Gamma-interferon (IFN-gamma) responses were evaluated by enzyme-linked immunospot assay in peripheral blood mononuclear cells from children with RV (n=26) or non-RV (n=10) gastroenteritis and from RV-exposed adults (n=10). Additionally, IL-4 responses were assessed in 5 of the 10 adults and 6 of 26 RV-infected children.


RESULTS
IFN-gamma secreting cells specific to whole RV were detected in 68% of RV-positive children and to NSP4 in 43% of these children between 4 and 30 days of illness onset. IFN-gamma responses were transient and were found higher in RV-exposed adults than in children (P<0.05). Within the RV-positive group, IFN-gamma responses in children with prior RV-exposure were higher than children without prior exposure (P<0.05). The response to whole RV and NSP4 were positively correlated (P<0.01, r(s)=0.66).


CONCLUSIONS
Significant IFN-gamma responses to rotavirus candidate vaccine strain 116E were detected in children during natural RV-infection and in RV-exposed adults. Significant IFN-gamma responses to NSP4 were also observed in these study groups.
Malik
Jyoti
J
Center for Diarrheal Disease Research, Department of Pediatrics, III Floor, Teaching Block, All India Institute of Medical Sciences, Ansari Nagar, New Delhi 110029, India.
Gupta
Santosh K
SK
Bhatnagar
Shinjini
S
Bhan
Maharaj K
MK
Ray
Pratima
P
D000328:Adult; D002675:Child, Preschool; D003967:Diarrhea / Q000276:immunology* / Q000503:physiopathology / Q000821:virology; D004797:Enzyme-Linked Immunosorbent Assay / Q000379:methods; D006023:Glycoproteins / Q000276:immunology*; D006801:Humans; D007371:Interferon-gamma / Q000378:metabolism*; D007963:Leukocytes, Mononuclear / Q000276:immunology; D012401:Rotavirus / Q000276:immunology*; D012400:Rotavirus Infections / Q000276:immunology* / Q000503:physiopathology / Q000821:virology; D022243:Rotavirus Vaccines / Q000276:immunology; D014118:Toxins, Biological / Q000276:immunology*; D017361:Viral Nonstructural Proteins / Q000276:immunology*
D006023:Glycoproteins; C081369:NS28 protein, rotavirus; D022243:Rotavirus Vaccines; D014118:Toxins, Biological; D017361:Viral Nonstructural Proteins; D007371:Interferon-gamma